Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

90.30

89.79

89.68

89.57

89.55

Share application money

2.32

2.45

4.72

5.72

7.57

Preference share capital

-

-

-

-

-

Reserves & surplus

3,362.43

3,314.44

3,153.66

3,079.88

3,159.68

Loan funds

Secured loans

1,349.20

1,244.63

841.04

852.46

808.95

Unsecured loans

-

-

-

-

-

Total

4,804.26

4,651.32

4,089.10

4,027.62

4,065.75

Uses of funds

Fixed assets

Gross block

1,058.56

1,042.53

999.08

886.05

776.49

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

462.00

425.62

354.59

270.38

202.87

Net block

596.56

616.91

644.49

615.67

573.61

Capital work-in-progress

55.38

55.72

110.67

108.81

122.46

Investments

2,491.77

2,399.76

2,394.65

2,170.57

2,148.87

Net current assets

Current assets, loans & advances

2,476.03

2,361.47

2,071.52

1,780.20

1,817.85

Less : current liabilities & provisions

815.49

782.54

1,132.24

647.63

597.05

Total net current assets

1,660.55

1,578.93

939.29

1,132.58

1,220.80

Miscellaneous expenses not written

-

-

-

-

-

Total

4,804.26

4,651.32

4,089.10

4,027.62

4,065.75

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

154.29

Contingent liabilities

632.08

2,345.08

1,929.34

3,498.11

5,766.31

Number of equity sharesoutstanding (Lacs)

903.03

897.90

896.81

895.65

895.49